Back to search results

Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus

Abroad (travel likely)RecruitingPHASE2

Conditions

Renal Cancer · Kidney Cancer · Renal Cell Carcinoma · Inferior Vena Cava Thrombosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Colorado Cancer Center, Aurora, Colorado, United States

    Contact: Study coordinator (Elizabeth Kessler) · elizabeth.kessler@cuanschutz.edu · 7208480170
    Corbin Eule, MD (Sub-investigator)
    Sandra Everett, FNP, MSN, RN (Sub-investigator)

  • Hilands Ranch Hospital, Highlands Ranch, Colorado, United States

    Contact: Study coordinator (Matthew Lee) · matthew.lee@cuanschutz.edu · 720-848-0630
    Contact: Principal Investigator (Elizabeth Kessler, MD)

  • Lone Tree Medical Center, Lone Tree, Colorado, United States

    Contact: Study coordinator (Matthew Lee) · matthew.lee@cuanschutz.edu · 720-848-0630
    Contact: Principal Investigator (Elizabeth Kessler, MD)
Study leads

  • Elizabeth E Kessler, MD

    Principal Investigator

    University of Colorado, Denver

View source on ClinicalTrials.gov(opens in a new tab)